In fiscal year 2202, the Japanese pharmaceutical company Takeda Pharmaceutical Co., Ltd. recorded R&D expenses of approximately 633 billion Japanese yen. The company focuses mainly on the therapeutic areas of oncology, gastroenterology, and neuroscience.
Research and development expenses of Takeda Pharmaceutical Co., Ltd. from fiscal year 2013 to 2022
(in billion Japanese yen)
fiscal year 2013 to 2022; the company’s fiscal year starts on April 1 of the stated year and ends on March 31 of the following year
Special properties
consolidated data of Takeda Pharmaceutical Co., Ltd. and its subsidiaries
Supplementary notes
Takeda has adopted International Financial Reporting Standards (IFRS) from fiscal 2013 and the disclosure information in this material is based on IFRS. According to this adoption, the previous year's information is also based on IFRS.
Figures prior to fiscal 2021 come from previous reporting.
reporting. Figures have been rounded. 100 Japanese yen equal 0.71 U.S. dollars or 0.64 euros as of January 2024.
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how Statista can support your business.
Takeda Pharmaceutical Company. (June 28, 2023). Research and development expenses of Takeda Pharmaceutical Co., Ltd. from fiscal year 2013 to 2022 (in billion Japanese yen) [Graph]. In Statista. Retrieved November 10, 2024, from https://www-statista-com.ezproxy.canberra.edu.au/statistics/797062/takeda-pharmaceutical-research-and-development-expenses/
Takeda Pharmaceutical Company. "Research and development expenses of Takeda Pharmaceutical Co., Ltd. from fiscal year 2013 to 2022 (in billion Japanese yen)." Chart. June 28, 2023. Statista. Accessed November 10, 2024. https://www-statista-com.ezproxy.canberra.edu.au/statistics/797062/takeda-pharmaceutical-research-and-development-expenses/
Takeda Pharmaceutical Company. (2023). Research and development expenses of Takeda Pharmaceutical Co., Ltd. from fiscal year 2013 to 2022 (in billion Japanese yen). Statista. Statista Inc.. Accessed: November 10, 2024. https://www-statista-com.ezproxy.canberra.edu.au/statistics/797062/takeda-pharmaceutical-research-and-development-expenses/
Takeda Pharmaceutical Company. "Research and Development Expenses of Takeda Pharmaceutical Co., Ltd. from Fiscal Year 2013 to 2022 (in Billion Japanese Yen)." Statista, Statista Inc., 28 Jun 2023, https://www-statista-com.ezproxy.canberra.edu.au/statistics/797062/takeda-pharmaceutical-research-and-development-expenses/
Takeda Pharmaceutical Company, Research and development expenses of Takeda Pharmaceutical Co., Ltd. from fiscal year 2013 to 2022 (in billion Japanese yen) Statista, https://www-statista-com.ezproxy.canberra.edu.au/statistics/797062/takeda-pharmaceutical-research-and-development-expenses/ (last visited November 10, 2024)
Research and development expenses of Takeda Pharmaceutical Co., Ltd. from fiscal year 2013 to 2022 (in billion Japanese yen) [Graph], Takeda Pharmaceutical Company, June 28, 2023. [Online]. Available: https://www-statista-com.ezproxy.canberra.edu.au/statistics/797062/takeda-pharmaceutical-research-and-development-expenses/
